SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as a major expanding national and international health problem. Despite numerous investigations using a variety of therapeutic agents, the positive result on any single medication has not been established enough to gain widespread a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharaibeh, Naser Eddin, Rahhal, Marie-Noel, Rahimi, Leili, Ismail-Beigi, Faramarz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613609/
https://www.ncbi.nlm.nih.gov/pubmed/31308716
http://dx.doi.org/10.2147/DMSO.S212715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613609/
https://www.ncbi.nlm.nih.gov/pubmed/31308716
http://dx.doi.org/10.2147/DMSO.S212715

Ejemplares similares